For help on how to get the results you want, see our search tips.
1172 results
Categories
Human Remove Human filter
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Paediatric investigation plans Remove Paediatric investigation plans filter
Authorisation status
Authorised Remove Authorised filter
-
List item
Human medicine European public assessment report (EPAR): Ebymect (updated)
dapagliflozin propanediol monohydrate, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 15/11/2015, Revision: 15, Authorised, Last updated: 22/09/2020 -
List item
Human medicine European public assessment report (EPAR): Exjade (updated)
deferasirox, beta-Thalassemia, Iron Overload
Date of authorisation: 28/08/2006,
, Revision: 47, Authorised, Last updated: 22/09/2020
-
List item
Human medicine European public assessment report (EPAR): Humira (updated)
adalimumab, Spondylitis, Ankylosing, Arthritis, Juvenile Rheumatoid, Uveitis, Colitis, Ulcerative, Psoriasis, Arthritis, Psoriatic, Crohn Disease, Arthritis, Rheumatoid
Date of authorisation: 08/09/2003, Revision: 77, Authorised, Last updated: 22/09/2020 -
List item
Human medicine European public assessment report (EPAR): Duloxetine Lilly (updated)
duloxetine, Neuralgia, Diabetic Neuropathies, Depressive Disorder, Major
Date of authorisation: 08/12/2014, Revision: 8, Authorised, Last updated: 22/09/2020 -
List item
Human medicine European public assessment report (EPAR): Tamiflu (updated)
oseltamivir, Influenza, Human
Date of authorisation: 20/06/2002, Revision: 39, Authorised, Last updated: 22/09/2020 -
List item
Human medicine European public assessment report (EPAR): Yentreve (updated)
duloxetine hydrochloride, Urinary Incontinence, Stress
Date of authorisation: 11/08/2004, Revision: 27, Authorised, Last updated: 22/09/2020 -
List item
Human medicine European public assessment report (EPAR): Cancidas (previously Caspofungin MSD) (updated)
caspofungin, Candidiasis, Aspergillosis
Date of authorisation: 23/10/2001, Revision: 26, Authorised, Last updated: 22/09/2020 -
List item
Human medicine European public assessment report (EPAR): Entresto (updated)
sacubitril, valsartan, Heart Failure
Date of authorisation: 19/11/2015, Revision: 11, Authorised, Last updated: 21/09/2020 -
List item
Human medicine European public assessment report (EPAR): Avamys (updated)
fluticasone furoate, Rhinitis, Allergic, Seasonal, Rhinitis, Allergic, Perennial
Date of authorisation: 11/01/2008, Revision: 20, Authorised, Last updated: 21/09/2020 -
List item
Human medicine European public assessment report (EPAR): Relistor (updated)
methylnaltrexone bromide, Opioid-Related Disorders, Constipation
Date of authorisation: 01/07/2008, Revision: 16, Authorised, Last updated: 21/09/2020 -
List item
Human medicine European public assessment report (EPAR): Strensiq (updated)
asfotase alfa, Hypophosphatasia
Date of authorisation: 28/08/2015,, 
, 
, Revision: 13, Authorised, Last updated: 21/09/2020
-
List item
Human medicine European public assessment report (EPAR): Elmiron (updated)
pentosan polysulfate sodium, Cystitis, Interstitial
Date of authorisation: 02/06/2017, Revision: 11, Authorised, Last updated: 21/09/2020 -
List item
Human medicine European public assessment report (EPAR): Pemetrexed medac (updated)
pemetrexed, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Date of authorisation: 26/11/2015,
, Revision: 6, Authorised, Last updated: 21/09/2020
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel / Acetylsalicylic acid Mylan (updated)
acetylsalicylic acid, clopidogrel hydrogen sulfate, Acute Coronary Syndrome, Myocardial Infarction
Date of authorisation: 09/01/2020,, Revision: 1, Authorised, Last updated: 21/09/2020
-
List item
Human medicine European public assessment report (EPAR): Voriconazole Hikma (previously Voriconazole Hospira) (updated)
voriconazole, Bacterial Infections and Mycoses, Aspergillosis, Candidiasis
Date of authorisation: 27/05/2015,, Revision: 8, Authorised, Last updated: 21/09/2020
-
List item
Human medicine European public assessment report (EPAR): Cuprior (updated)
Trientine tetrahydrochloride, Hepatolenticular Degeneration
Date of authorisation: 05/09/2017, Revision: 5, Authorised, Last updated: 21/09/2020 -
List item
Human medicine European public assessment report (EPAR): Imnovid (previously Pomalidomide Celgene) (updated)
Pomalidomide, Multiple Myeloma
Date of authorisation: 05/08/2013,, , Revision: 16, Authorised, Last updated: 21/09/2020
-
List item
Human medicine European public assessment report (EPAR): Epidyolex (updated)
Cannabidiol, Lennox Gastaut Syndrome, Epilepsies, Myoclonic
Date of authorisation: 19/09/2019,, Revision: 4, Authorised, Last updated: 18/09/2020
-
List item
Human medicine European public assessment report (EPAR): Xeljanz (updated)
tofacitinib citrate, Arthritis, Rheumatoid
Date of authorisation: 21/03/2017,
Date of refusal: 25/04/2013,
, , Revision: 12, Authorised, Last updated: 18/09/2020
-
List item
Human medicine European public assessment report (EPAR): Sildenafil Actavis (updated)
sildenafil, Erectile Dysfunction
Date of authorisation: 10/12/2009,, Revision: 13, Authorised, Last updated: 18/09/2020
-
List item
Human medicine European public assessment report (EPAR): Apidra (updated)
insulin glulisine, Diabetes Mellitus
Date of authorisation: 27/09/2004, Revision: 29, Authorised, Last updated: 18/09/2020 -
List item
Human medicine European public assessment report (EPAR): Truvada (updated)
emtricitabine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 20/02/2005, Revision: 43, Authorised, Last updated: 17/09/2020 -
List item
Human medicine European public assessment report (EPAR): Ruxience (updated)
rituximab, Leukemia, Lymphocytic, Chronic, B-Cell, Arthritis, Rheumatoid, Microscopic Polyangiitis, Pemphigus
Date of authorisation: 01/04/2020,, 
, Revision: 2, Authorised, Last updated: 17/09/2020
-
List item
Human medicine European public assessment report (EPAR): Bortezomib Sun (updated)
bortezomib, Multiple Myeloma
Date of authorisation: 22/07/2016,, Revision: 8, Authorised, Last updated: 17/09/2020
-
List item
Human medicine European public assessment report (EPAR): Hizentra (updated)
human normal immunoglobulin (SCIg), Immunologic Deficiency Syndromes
Date of authorisation: 14/04/2011, Revision: 20, Authorised, Last updated: 16/09/2020